Hologic (HOLX) Tops Q4 EPS by 61c

Hologic (NASDAQ: HOLX) reported Q4 EPS of $1.61, $0.61 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Hologic sees Q1 2022 EPS of $1.15-$1.25, versus the consensus of $0.96. Hologic sees Q1 2022 revenue of $1.1-1.15 billion, versus the consensus of $0.99163 billion.

Hologic sees FY2022 EPS of $3.55-$3.85, versus the consensus of $3.69. Hologic sees FY2022 revenue of $3.75-4 billion, versus the consensus of $3.87 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Hologic recalls BioZorb markers after reported injuries - FDA
• ​Trump said he was unaware of his earnings from crypto
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance